Facebook Linkedin Soundcloud Twitter Vimeo Xing
Home Tags STING pathway

Tag: STING pathway

Merck KGaA and Mersana Therapeutics Sign Research Collaboration and Commercial License...

ADC Review | Editorial Team
German based Merck KGaA, and Mersana Therapeutics USA have signed a research collaboration and commercial license agreement to discover novel antibody-drug conjugates (ADCs) leveraging...

Mersana and GSK Sign Option Agreement for the Co-Development and Commercialization...

ADC Review | Editorial Team
Mersana Therapeutics and GSK have confirmed that the companies have entered into a global collaboration that provides GSK an exclusive option to co-develop and...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X